BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37964213)

  • 1. Dutch, UK and US professionals' perceptions of screening for Barrett's esophagus and esophageal adenocarcinoma: a concept mapping study.
    Sijben J; Rainey L; Peters Y; Fitzgerald RC; Wani S; Kolb JM; Broeders MJM; Siersema PD
    BMC Cancer; 2023 Nov; 23(1):1111. PubMed ID: 37964213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Professionals' views on the justification for esophageal adenocarcinoma screening: A systematic literature search and qualitative analysis.
    Sijben J; Peters Y; Rainey L; Gashi M; Broeders MJM; Siersema PD
    Prev Med Rep; 2023 Aug; 34():102264. PubMed ID: 37273526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions.
    Kroep S; Lansdorp-Vogelaar I; van der Steen A; Inadomi JM; van Ballegooijen M
    Med Decis Making; 2015 Aug; 35(6):726-33. PubMed ID: 25277672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.
    Hammad TA; Thrift AP; El-Serag HB; Husain NS
    Dig Dis Sci; 2019 Feb; 64(2):367-372. PubMed ID: 30370493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoscale markers of esophageal field carcinogenesis: potential implications for esophageal cancer screening.
    Konda VJ; Cherkezyan L; Subramanian H; Wroblewski K; Damania D; Becker V; Gonzalez MH; Koons A; Goldberg M; Ferguson MK; Waxman I; Roy HK; Backman V
    Endoscopy; 2013 Dec; 45(12):983-8. PubMed ID: 24019132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions.
    Sami SS; Ragunath K; Iyer PG
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):623-34. PubMed ID: 24887058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide.
    Ghaus S; Neumann H; Muhammad H; Tontini GE; Ishaq S
    Dig Dis Sci; 2016 Aug; 61(8):2185-2193. PubMed ID: 27038446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.
    Whiteman DC; Appleyard M; Bahin FF; Bobryshev YV; Bourke MJ; Brown I; Chung A; Clouston A; Dickins E; Emery J; Eslick GD; Gordon LG; Grimpen F; Hebbard G; Holliday L; Hourigan LF; Kendall BJ; Lee EY; Levert-Mignon A; Lord RV; Lord SJ; Maule D; Moss A; Norton I; Olver I; Pavey D; Raftopoulos S; Rajendra S; Schoeman M; Singh R; Sitas F; Smithers BM; Taylor AC; Thomas ML; Thomson I; To H; von Dincklage J; Vuletich C; Watson DI; Yusoff IF
    J Gastroenterol Hepatol; 2015 May; 30(5):804-20. PubMed ID: 25612140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study.
    Menon S; Nightingale P; Trudgill N
    J Clin Gastroenterol; 2019; 53(10):e451-e455. PubMed ID: 31008868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovations in Screening Tools for Barrett's Esophagus and Esophageal Adenocarcinoma.
    Bell MG; Iyer PG
    Curr Gastroenterol Rep; 2021 Oct; 23(12):22. PubMed ID: 34654955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.
    Gaddam S; Singh M; Balasubramanian G; Thota P; Gupta N; Wani S; Higbee AD; Mathur SC; Horwhat JD; Rastogi A; Young PE; Cash BD; Bansal A; Vargo JJ; Falk GW; Lieberman DA; Sampliner RE; Sharma P
    Gastroenterology; 2013 Sep; 145(3):548-53.e1. PubMed ID: 23714382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Barrett's esophagus in relatives by endoscopic screening.
    Chak A; Faulx A; Kinnard M; Brock W; Willis J; Wiesner GL; Parrado AR; Goddard KA
    Am J Gastroenterol; 2004 Nov; 99(11):2107-14. PubMed ID: 15554988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
    Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
    World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma.
    Sawas T; Zamani SA; Killcoyne S; Dullea A; Wang KK; Iyer PG; Fitzgerald RC; Katzka DA
    Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1709-1718. PubMed ID: 34757196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett's esophagus.
    Ishihara R; Goda K; Oyama T
    J Gastroenterol; 2019 Jan; 54(1):1-9. PubMed ID: 29961130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.
    Kamboj AK; Katzka DA; Iyer PG
    Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):27-41. PubMed ID: 33213798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnitude and Time-Trends of Post-Endoscopy Esophageal Adenocarcinoma and Post-Endoscopy Esophageal Neoplasia in a Population-Based Cohort Study: The Nordic Barrett's Esophagus Study.
    Wani S; Holmberg D; Santoni G; Kauppila JH; Farkkila M; von Euler-Chelpin M; Shaheen NJ; Lagergren J
    Gastroenterology; 2023 Oct; 165(4):909-919.e13. PubMed ID: 37279832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett's Esophagus-Related Neoplasia: A Feasibility Study.
    Everson M; Magee C; Alzoubaidi D; Brogden S; Graham D; Lovat LB; Novelli M; Haidry R
    Dig Dis Sci; 2019 Oct; 64(10):2815-2822. PubMed ID: 30982210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma.
    Garman KS; Orlando RC; Chen X
    Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1231-43. PubMed ID: 22421618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.